AstraZeneca inks $800M buyout of French biotech to snag phase 3 rare disease drug

0

14.03.2024 16:48

Fiercebiotech.com

AstraZeneca inks $800M buyout of French biotech to snag phase 3 rare disease drug ntaylor Thu, 03/14/2024 - 09:48

СМИ24.net — правдивые новости, непрерывно 24/7 на русском языке с ежеминутным обновлением *